Experimental Pill Nearly Doubles Survival Rates
Share on PinterestAn experimental new pill, daraxonrasib, significantly improved survival rates of participants with pancreatic cancer. Israel Sebastian/Getty Images A new medication performed remarkably well in a phase 3 clinical trial for treating pancreatic cancer. The drug daraxonrasib reduced the risk of death by nearly half, as well as shrank tumors in people who were […]
